Data_Sheet_4_Decreased default mode network functional connectivity with visual processing regions as potential biomarkers for delayed neurocognitive recovery: A resting-state fMRI... حسب Zhaoshun Jiang (7478243)

"…The algorithm performance was evaluated by a permutation test.</p>Results<p>We found significantly decreased DMN connectivity with the brain regions involved in visual processing in DNR patients than in non-DNR patients. …"

Data_Sheet_3_Decreased default mode network functional connectivity with visual processing regions as potential biomarkers for delayed neurocognitive recovery: A resting-state fMRI... حسب Zhaoshun Jiang (7478243)

"…The algorithm performance was evaluated by a permutation test.</p>Results<p>We found significantly decreased DMN connectivity with the brain regions involved in visual processing in DNR patients than in non-DNR patients. …"

Data_Sheet_1_Decreased default mode network functional connectivity with visual processing regions as potential biomarkers for delayed neurocognitive recovery: A resting-state fMRI... حسب Zhaoshun Jiang (7478243)

"…The algorithm performance was evaluated by a permutation test.</p>Results<p>We found significantly decreased DMN connectivity with the brain regions involved in visual processing in DNR patients than in non-DNR patients. …"

Data_Sheet_1_Decreased default mode network functional connectivity with visual processing regions as potential biomarkers for delayed neurocognitive recovery: A resting-state fMRI... حسب Zhaoshun Jiang (7478243)

"…The algorithm performance was evaluated by a permutation test.</p>Results<p>We found significantly decreased DMN connectivity with the brain regions involved in visual processing in DNR patients than in non-DNR patients. …"

Data_Sheet_2_Decreased default mode network functional connectivity with visual processing regions as potential biomarkers for delayed neurocognitive recovery: A resting-state fMRI... حسب Zhaoshun Jiang (7478243)

"…The algorithm performance was evaluated by a permutation test.</p>Results<p>We found significantly decreased DMN connectivity with the brain regions involved in visual processing in DNR patients than in non-DNR patients. …"

The aging-induced decrease in the number of dendritic branches in neurons of the hippocampus and cerebral cortex was attenuated by the administration of GTDE. حسب Hui-Chuan Kuo (12368492)

Fig 1 - حسب Dalia Zaafar (6693017)

الموضوعات:

Fig 3 - حسب Dalia Zaafar (6693017)

الموضوعات:

Fig 5 - حسب Dalia Zaafar (6693017)

الموضوعات:

Photomicrographs representing Bcl-2 immunoreactivity in the sarcoplasm of cardiomyocytes of mice of different groups. حسب Dalia Zaafar (6693017)

الموضوعات:

Photomicrographs representing caspase-3 immunoreactivity in the sarcoplasm of cardiomyocytes of mice of different groups. حسب Dalia Zaafar (6693017)

الموضوعات:

Contains all data used in the study. حسب Dalia Zaafar (6693017)

الموضوعات:

Fig 4 - حسب Dalia Zaafar (6693017)

الموضوعات:

Effect of sorafenib alone or added to hesperetin on the expression of NLRP3 inflammasome and TLR4 via western blotting in different groups. حسب Dalia Zaafar (6693017)

الموضوعات:

Representative standard curves for (A) total phenolic content; (B) flavonoid content. حسب Shivankar Agrawal (11565095)

الموضوعات:

SIINFEKL-specific CD8⁺ T cells treated with anti-CXCR3 decreased the polyfunctionality. حسب Camila Pontes Ferreira (6194006)

The synchronous activity of SGN fiber populations is disrupted and their response to sound is decreased with increasing levels of <i>L</i>_<i>u</i> heterogeneity. حسب Maral Budak (6680351)

Flow chart of the study procedures. حسب Kazuhiko Ikeuchi (9234268)

"…Pre-treatment spontaneous decrease of RPR titer was associated with a slower decrease in post-treatment RPR titer.…"

Table 1_Previous treatment decreases efficacy of pralsetinib in RET fusion-positive non-small-cell lung cancer.doc حسب Lei Wang (6656)

"…Background<p>Pralsetinib is a selective RET inhibitor. The ARROW trial revealed that RET fusion-positive non-small-cell lung cancer (NSCLC) can benefit from pralsetinib with tolerable adverse events (AEs). …"

Dose-dependent decreases in cell viability with carboplatin, mitoxantrone, vinblastine, and CBD treatment of canine UC cells. حسب Jordon M. Inkol (11237604)